Interrelationship between endothelial dysfunction, IMT of the carotid arteries and adhesion molecules in obese hypertensive children and adolescents;Dysfunkcja śródbłonka, grubość kompleksu IMT tȩtnic szyjnych wspólnych i cza̧steczki adhezyjne u dzieci i młodzieży z otyłościa̧ i nadciśnieniem - Analiza wzajemnych korelacji

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 13, Issue 1, 2007, Pages 7-14

  Głowińska Olszewska, Barbara ^a   Tołwińska, Joanna ^a   Urban, Mirosława ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adhesion molecules; Adolescents; Children; Endothelial dysfunction; FMD; Hypertension; IMT; Obesity

Indexed keywords

ADHESIN; BIOCHEMICAL MARKER; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIAL DYSFUNCTION; ENZYME IMMUNOASSAY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OBESITY; SCHOOL CHILD; ULTRASOUND; VASODILATATION;

EID: 84859901405     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Behrendt D., Ganz P.: Endothelial function. From vascular biology to clinical applications. Am. J. Cardiol., 2002, 90, 40L-48L.
2. Celermajer D.S.: Noninvasive detection of atherosclerosis. N. Engl. J. Med., 1998, 339, 2014-2015.
3. Widlansky M.E., Gokce N., Keaney J.F. Jr i wsp.: The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol., 2003, 42, 1149-1160.
4. Libby P., Ridker P.M., Maseri A.: Inflammation and atherosclerosis. Circulation, 2002, 105, 1135-1143.
5. Ross R.: Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 1999, 340, 115-126.
6. Blake G.J., Ridker P.M:. Novel clinical markers of vascular wall inflammation. Circ. Res., 2001, 89, 763-771.
7. Huang A.L., Vita J.A:. Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovasc. Med., 2006, 16, 15-20.
8. Blankenberg S., Barbaux S., Tiret L.: Adhesion molecules and atherosclerosis. Atherosclerosis, 2003, 170, 191-203.
9. Blann A.D., Lip G.Y.: The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. Blood Coagul. Fibrinolysis, 1998, 9, 297-306.
10. Hillis G.S., Flapan A.D.: Cell adhesion molecules in cardiovascular disease: a clinical perspective. Heart, 1998, 79, 429-431.
11. Hunt B.J., Jurd K.M.: Endothelial cell activation. A central pathophysiological process. BMJ, 1998, 316, 1328-1329.
12. Slyper A.H.: Clinical review 168: what vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J. Clin. Endocrinol. Metab., 2004, 89, 3089-95.
13. Rembold K.E., Ayers C.R., Wills M.B. i wsp.: Usefulness of carotid intimal medial thickness and flow-mediated dilation in a preventive cardiovascular practice. Am. J. Cardiol., 2003, 91, 1475-1477, A8.
14. Palczewska I., Niedzwiedzka Z.: Somatic development indices in children and youth of Warsaw. Med. Wieku Rozwoj., 2001, 5, 18-118.
15. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics, 1996, 98, 649-658.
16. Radziuk J.: Insulin sensitivity and its measurement: structural commonalities among the methods. J. Clin. Endocrinol. Metab., 2000, 85, 44264433.
17. Celermajer D.S., Sorensen K.E., Gooch V.M. i wsp.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992, 340, 1111-1115.
18. Pignoli P., Tremoli E., Poli A. i wsp.: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation, 1986, 74, 1399-1406.
19. Reinehr T., Kiess W., de Sousa G. i wsp.: Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism, 2006, 55, 113-118.
20. Jarvisalo M.J., Raitakari M., Toikka J.O. i wsp.: Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation, 2004, 109, 1750-1755.
21. Singh T.P., Groehn H., Kazmers A.: Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol., 2003, 41, 661-665.
22. Jarvisalo M.J., Harmoinen A., Hakanen M. i wsp.: Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler. Thromb. Vasc. Biol., 2002, 22, 1323-1328.
23. Vita J.A., Keaney J.F. Jr.: Endothelial function: a barometer for cardiovascular risk? Circulation, 2002, 106, 640-642.
24. Witte D.R., Broekmans W.M., Kardinaal A.F. i wsp.: Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis, 2003, 170, 147-53.
25. Holmlund A., Hulthe J., Millgard J. i wsp.: Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals. Atherosclerosis, 2002, 165, 271-276.
26. Glowinska-Olszewska B., Urban M., Tolwinska J. i wsp. Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1. Endokrynol. Diabetol. Chor. Przemiany Materii Wieku Rozw., 2005, 11, 221-227.
27. Rizzoni D., Muiesan M.L., Porteri E. i wsp.: Circulating adhesion molecules and carotid artery structural changes in patients with noninsulin-dependent diabetes mellitus. J. Hum. Hypertens., 2003, 17, 463-470.
28. Berenson G.S., Srinivasan S.R., Bao W. i wsp.: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N. Engl. J. Med., 1998, 338, 1650-1656.
29. Hwang S.J., Ballantyne C.M., Sharrett A.R. i wsp.: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation, 1997, 96, 4219-4225.
30. Rohde L.E., Lee R.T., Rivero J. i wsp.: Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 1998, 18, 1765-1770.
31. Kondo K., Kitagawa K., Nagai Y. i wsp.: Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis, 2005, 179, 155-160.
32. Blann A.D., Lip G.Y.: Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus. Diabet. Med., 1998, 15, 634-642.
33. Cominacini L., Fratta Pasini A., Garbin U. i wsp.: Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia, 1995, 38, 1122-1124.
34. de Lemos J.A., Hennekens C.H., Ridker P.M.: Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. J. Am. Coll. Cardiol., 2000, 36, 423-426.
35. Davies M.J., Gordon J.L., Gearing A.J. i wsp.: The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol., 1993, 171, 223-229.
36. Leinonen E,. Hurt-Camejo E., Wiklund O. i wsp.: Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis, 2003, 166, 387-394.
37. Balletshofer B.M., Rittig K., Stock J. i wsp.: Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but no differences in intima-media thickness. Atherosclerosis, 2003, 171, 303-309.
38. Suzuki M., Takamisawa I., Suzuki K. i wsp.: Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. Am. J. Hypertens,. 2004, 17, 228-232.
39. Zavaroni I., Ardigo D., Zuccarelli A. i wsp.: Insulin resistance/compensatory hyperinsulinemia predict carotid intimal medial thickness in patients with essential hypertension. Nutr. Metab. Cardiovasc. Dis,. 2006, 16, 22-27.
40. Steinberg H.O., Brechtel G., Johnson A. i wsp.: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest., 1994, 94, 1172-1179.
41. Cardillo C., Nambi S.S., Kilcoyne CM. i wsp.: Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation, 1999, 100, 820-825.
42. Anderson T.J.: Assessment and treatment of endothelial dysfunction in humans. J. Am. Coll. Cardiol., 1999, 34, 631-638.
43. Dogra G.K., Watts G.F., Chan D.C. i wsp.: Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria. Diabet. Med., 2005, 22, 239-242.
44. Hamdy O., Ledbury S., Mullooly C. i wsp.: Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care, 2003, 26, 2119-2125.
45. Watts K., Beye P., Siafarikas A. i wsp.: Effects of exercise training on vascular function in obese children. J. Pediatr., 2004, 144, 620-625.